Andrew T. Bender
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Andrew T. Bender has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Jonathan D. Posner
Department of Chemical Engineering, University of Washington, Seattle, Washington, USA
14 shared publications - Coleman D. Martin
Department of Chemical Engineering, University of Washington, Seattle, Washington, USA
6 shared publications - Benjamin P. Sullivan
Department of Mechanical Engineering, University of Washington, Seattle, Washington, USA
5 shared publications Lorraine Lillis
PATH, Seattle, Washington, USA
5 shared publications- Ayokunle Oluwafemi Olanrewaju
Department of Bioengineering, University of Washington
4 shared publications Benjamin P. Sullivan
Affiliation Department of Mechanical Engineering, University of Washington, Seattle, Washington, United States of America
4 shared publications
Latest Publications
- Open Access
- 18 September 2026
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 5 (9) , 1144-1155
PEG-mediated viscous crowding controls dynamics and quantitative range in recombinase polymerase amplification nucleation site analysis
PEG-tuned viscous crowding enables compartment-free digital RPA with four-log absolute quantification in a simple microfluidic chip.
- 18 September 2026
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 5 (9) , 1144-1155
Open AccessPEG-mediated viscous crowding controls dynamics and quantitative range in recombinase polymerase amplification nucleation site analysis
PEG-tuned viscous crowding enables compartment-free digital RPA with four-log absolute quantification in a simple microfluidic chip.
- 21 January 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (4) , 2797-2806
Extraction-Free Scalable Sample Preparation for the Rapid Detection of HIV in Blood Plasma
Nucleic acid amplification tests that are rapid and low-cost are needed for expanding access to point-of-care (POC) diagnostics for infectious diseases and viral load monitoring. Several companies have commercialized POC devices using rapid isothermal amplification; however, these tests use nasal swabs or saliva samples. Translating these tests to blood plasma is challenging due to clotting factors, heat- or pH-induced coagulation of human albumin, high concentrations of ribonucleases (RNases), and other sample matrix inhibitors. Crude, extraction-free sample preparation methods are promising alternatives that reduce the complexity of sample preparation. In this paper, we present an extraction-free sample preparation method for in-tube and paper-based reverse transcription recombinase polymerase amplification for the detection of HIV in blood plasma samples. We use a rapid heat treatment protocol with a reducing agent to inhibit RNases and lyse HIV virus, enabling RNA preservation into direct amplification without the need for complex RNA purification steps. We demonstrate sample treatment in 5 min and amplification within 20 min in reaction volumes ranging from 50 to 300 μL and show that large volume reactions achieve a limit of detection of 800 copies/mL (16 copies/reaction) for HIV-positive plasma in both paper and tube formats.
- 21 January 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (4) , 2797-2806
Extraction-Free Scalable Sample Preparation for the Rapid Detection of HIV in Blood Plasma
Nucleic acid amplification tests that are rapid and low-cost are needed for expanding access to point-of-care (POC) diagnostics for infectious diseases and viral load monitoring. Several companies have commercialized POC devices using rapid isothermal amplification; however, these tests use nasal swabs or saliva samples. Translating these tests to blood plasma is challenging due to clotting factors, heat- or pH-induced coagulation of human albumin, high concentrations of ribonucleases (RNases), and other sample matrix inhibitors. Crude, extraction-free sample preparation methods are promising alternatives that reduce the complexity of sample preparation. In this paper, we present an extraction-free sample preparation method for in-tube and paper-based reverse transcription recombinase polymerase amplification for the detection of HIV in blood plasma samples. We use a rapid heat treatment protocol with a reducing agent to inhibit RNases and lyse HIV virus, enabling RNA preservation into direct amplification without the need for complex RNA purification steps. We demonstrate sample treatment in 5 min and amplification within 20 min in reaction volumes ranging from 50 to 300 μL and show that large volume reactions achieve a limit of detection of 800 copies/mL (16 copies/reaction) for HIV-positive plasma in both paper and tube formats.
- 20 September 2024
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (20) , 4879-4891
Vibration mixing for enhanced paper-based recombinase polymerase amplification
Disclosed herein is an interesting photoredox catalysis for the direct bisarylation of bromonitroalkanes with 2-arylindoles to provide a simplified synthetic route to 3,3′-diindolylmethane (DIM) derivatives, where the nitro functionality plays a dual role as an activating and leaving group. The bromonitroalkanes can be used in situ in a one-pot, two-step reaction to generate bis(indolyl)methanes in high yields. A wide range of 2-arylindoles is also successfully employed to create the corresponding bis(indolyl)methanes. A preliminary in vitro biological evaluation study demonstrates that these compounds possess promising α-glucosidase inhibitors (IC50 = 5.45 ± 0.64–28.06 ± 0.40 μM).
- 20 September 2024
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 24 (20) , 4879-4891
Vibration mixing for enhanced paper-based recombinase polymerase amplification
Disclosed herein is an interesting photoredox catalysis for the direct bisarylation of bromonitroalkanes with 2-arylindoles to provide a simplified synthetic route to 3,3′-diindolylmethane (DIM) derivatives, where the nitro functionality plays a dual role as an activating and leaving group. The bromonitroalkanes can be used in situ in a one-pot, two-step reaction to generate bis(indolyl)methanes in high yields. A wide range of 2-arylindoles is also successfully employed to create the corresponding bis(indolyl)methanes. A preliminary in vitro biological evaluation study demonstrates that these compounds possess promising α-glucosidase inhibitors (IC50 = 5.45 ± 0.64–28.06 ± 0.40 μM).
- Open Access
- 12 January 2024
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 3 (3) , 421-430
SARS-CoV-2 recombinase polymerase amplification assay with lateral flow readout and duplexed full process internal control
Here we report on a SARS-CoV-2 RPA assay for lateral flow strip detection format that incorporates a full process internal control that indicates the successful lysis, reverse transcription, and amplification of each viral sample.
- 12 January 2024
- Published by Royal Society of Chemistry (RSC) in Sensors & Diagnostics
- Vol. 3 (3) , 421-430
Open AccessSARS-CoV-2 recombinase polymerase amplification assay with lateral flow readout and duplexed full process internal control
Here we report on a SARS-CoV-2 RPA assay for lateral flow strip detection format that incorporates a full process internal control that indicates the successful lysis, reverse transcription, and amplification of each viral sample.
- Open Access
- 25 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (10) , e0276582
Rapid detection of hepatitis C virus using recombinase polymerase amplification
Over 71 million people are infected with hepatitis C virus (HCV) worldwide, and approximately 400,000 global deaths result from complications of untreated chronic HCV. Pan-genomic direct-acting antivirals (DAAs) have recently become widely available and feature high cure rates in less than 12 weeks of treatment. The rollout of DAAs is reliant on diagnostic tests for HCV RNA to identify eligible patients with viremic HCV infections. Current PCR-based HCV RNA assays are restricted to well-resourced central laboratories, and there remains a prevailing clinical need for expanded access to decentralized HCV RNA testing to provide rapid chronic HCV diagnosis and linkage to DAAs in outpatient clinics. This paper reports a rapid, highly accurate, and minimally instrumented assay for HCV RNA detection using reverse transcription recombinase polymerase amplification (RT-RPA). The assay detects all HCV genotypes with a limit of detection of 25 copies per reaction for genotype 1, the most prevalent in the United States and worldwide. The clinical sensitivity and specificity of the RT-RPA assay were both 100% when evaluated using 78 diverse clinical serum specimens. The accuracy, short runtime, and low heating demands of RT-RPA may enable implementation in a point-of-care HCV test to expand global access to effective treatment via rapid chronic HCV diagnosis.
- 25 October 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (10) , e0276582
Open AccessRapid detection of hepatitis C virus using recombinase polymerase amplification
Over 71 million people are infected with hepatitis C virus (HCV) worldwide, and approximately 400,000 global deaths result from complications of untreated chronic HCV. Pan-genomic direct-acting antivirals (DAAs) have recently become widely available and feature high cure rates in less than 12 weeks of treatment. The rollout of DAAs is reliant on diagnostic tests for HCV RNA to identify eligible patients with viremic HCV infections. Current PCR-based HCV RNA assays are restricted to well-resourced central laboratories, and there remains a prevailing clinical need for expanded access to decentralized HCV RNA testing to provide rapid chronic HCV diagnosis and linkage to DAAs in outpatient clinics. This paper reports a rapid, highly accurate, and minimally instrumented assay for HCV RNA detection using reverse transcription recombinase polymerase amplification (RT-RPA). The assay detects all HCV genotypes with a limit of detection of 25 copies per reaction for genotype 1, the most prevalent in the United States and worldwide. The clinical sensitivity and specificity of the RT-RPA assay were both 100% when evaluated using 78 diverse clinical serum specimens. The accuracy, short runtime, and low heating demands of RT-RPA may enable implementation in a point-of-care HCV test to expand global access to effective treatment via rapid chronic HCV diagnosis.
- Open Access
- 14 July 2022
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 8 (1) , e10369
REverSe TRanscrIptase chain termination (RESTRICT) for selective measurement of nucleotide analogs used in HIV care and prevention
Sufficient drug concentrations are required for efficacy of antiretroviral drugs used in HIV care and prevention. Measurement of nucleotide analogs, included in most HIV medication regimens, enables monitoring of short‐ and long‐term adherence and the risk of treatment failure. The REverSe TRanscrIptase Chain Termination (RESTRICT) assay rapidly infers the concentration of intracellular nucleotide analogs based on the inhibition of DNA synthesis by HIV reverse transcriptase enzyme. Here, we introduce a probabilistic model for RESTRICT and demonstrate selective measurement of multiple nucleotide analogs using DNA templates designed according to the chemical structure of each drug. We measure clinically relevant concentrations of tenofovir diphosphate, emtricitabine triphosphate, lamivudine triphosphate, and azidothymidine triphosphate with agreement between experiment and theory. RESTRICT represents a new class of activity‐based assays for therapeutic drug monitoring in HIV care and could be extended to other diseases treated with nucleotide analogs.
- 14 July 2022
- Published by Wiley in Bioengineering & Translational Medicine
- Vol. 8 (1) , e10369
Open AccessREverSe TRanscrIptase chain termination (RESTRICT) for selective measurement of nucleotide analogs used in HIV care and prevention
Sufficient drug concentrations are required for efficacy of antiretroviral drugs used in HIV care and prevention. Measurement of nucleotide analogs, included in most HIV medication regimens, enables monitoring of short‐ and long‐term adherence and the risk of treatment failure. The REverSe TRanscrIptase Chain Termination (RESTRICT) assay rapidly infers the concentration of intracellular nucleotide analogs based on the inhibition of DNA synthesis by HIV reverse transcriptase enzyme. Here, we introduce a probabilistic model for RESTRICT and demonstrate selective measurement of multiple nucleotide analogs using DNA templates designed according to the chemical structure of each drug. We measure clinically relevant concentrations of tenofovir diphosphate, emtricitabine triphosphate, lamivudine triphosphate, and azidothymidine triphosphate with agreement between experiment and theory. RESTRICT represents a new class of activity‐based assays for therapeutic drug monitoring in HIV care and could be extended to other diseases treated with nucleotide analogs.
- 14 June 2022
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 22 (12) , 2352-2363
Quantitative isothermal amplification on paper membranes using amplification nucleation site analysis
We report a novel method for the quantification of isothermal amplification reactions on paper membranes using discrete fluorescent amplification nucleation sites.
- 14 June 2022
- Published by Royal Society of Chemistry (RSC) in Lab on a Chip
- Vol. 22 (12) , 2352-2363
Quantitative isothermal amplification on paper membranes using amplification nucleation site analysis
We report a novel method for the quantification of isothermal amplification reactions on paper membranes using discrete fluorescent amplification nucleation sites.
- 31 March 2022
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 14 (13) , 1361-1370
HIV pre-exposure prophylaxis adherence test using reverse transcription isothermal amplification inhibition assay
We report on a probabilistic isothermal nucleic acid amplification assay for measuring a common medication in HIV prevention and treatment. Expanded access to routine HIV drug adherence testing is a crucial tool in improving the HIV care continuum.
- 31 March 2022
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 14 (13) , 1361-1370
HIV pre-exposure prophylaxis adherence test using reverse transcription isothermal amplification inhibition assay
We report on a probabilistic isothermal nucleic acid amplification assay for measuring a common medication in HIV prevention and treatment. Expanded access to routine HIV drug adherence testing is a crucial tool in improving the HIV care continuum.
- Open Access
Quantitative Isothermal Amplification on Paper Membranes using Amplification Nucleation Site Analysis
Quantitative nucleic acid amplification tests (qNAATs) are critical in treating infectious diseases, such as in HIV viral load monitoring or SARS-CoV-2 testing, in which viral load indicates viral suppression or infectivity. Quantitative PCR is the gold standard tool for qNAATs; however, there is a need to develop point-of-care (POC) qNAATs to manage infectious diseases in outpatient clinics, low- and middle-income countries, and the home. Isothermal amplification methods are an emerging tool for POC NAATs as an alternative to traditional PCR-based workflows. Previous works have focused on relating isothermal amplification bulk fluorescence signals to input copies of target nucleic acids for sample quantification with limited success. In this work, we show that recombinase polymerase amplification (RPA) reactions on paper membranes exhibit discrete fluorescent amplification nucleation sites. We demonstrate that the number of nucleation sites can be used to quantify HIV-1 DNA and RNA in less than 20 minutes. An image-analysis algorithm quantifies nucleation sites and determines the input nucleic acid copies in the range of 67-3,000 copies per reaction. We demonstrate a mobile phone-based system for image capture and onboard processing, illustrating that this method may be used at the point-of-care for qNAATs with minimal instrumentation.
Open AccessQuantitative Isothermal Amplification on Paper Membranes using Amplification Nucleation Site Analysis
Quantitative nucleic acid amplification tests (qNAATs) are critical in treating infectious diseases, such as in HIV viral load monitoring or SARS-CoV-2 testing, in which viral load indicates viral suppression or infectivity. Quantitative PCR is the gold standard tool for qNAATs; however, there is a need to develop point-of-care (POC) qNAATs to manage infectious diseases in outpatient clinics, low- and middle-income countries, and the home. Isothermal amplification methods are an emerging tool for POC NAATs as an alternative to traditional PCR-based workflows. Previous works have focused on relating isothermal amplification bulk fluorescence signals to input copies of target nucleic acids for sample quantification with limited success. In this work, we show that recombinase polymerase amplification (RPA) reactions on paper membranes exhibit discrete fluorescent amplification nucleation sites. We demonstrate that the number of nucleation sites can be used to quantify HIV-1 DNA and RNA in less than 20 minutes. An image-analysis algorithm quantifies nucleation sites and determines the input nucleic acid copies in the range of 67-3,000 copies per reaction. We demonstrate a mobile phone-based system for image capture and onboard processing, illustrating that this method may be used at the point-of-care for qNAATs with minimal instrumentation.
- 6 April 2021
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 146 (9) , 2851-2861
HIV detection from human serum with paper-based isotachophoretic RNA extraction and reverse transcription recombinase polymerase amplification
An HIV detection assay featuring a low-cost μPAD for electrophoretic RNA extraction and rapid isothermal nucleic acid amplification.
- 6 April 2021
- Published by Royal Society of Chemistry (RSC) in The Analyst
- Vol. 146 (9) , 2851-2861
HIV detection from human serum with paper-based isotachophoretic RNA extraction and reverse transcription recombinase polymerase amplification
An HIV detection assay featuring a low-cost μPAD for electrophoretic RNA extraction and rapid isothermal nucleic acid amplification.